A novel substrate for arrhythmias in Chagas disease
- PMID: 34077437
- PMCID: PMC8172059
- DOI: 10.1371/journal.pntd.0009421
A novel substrate for arrhythmias in Chagas disease
Abstract
Background: Chagas disease (CD) is a neglected disease that induces heart failure and arrhythmias in approximately 30% of patients during the chronic phase of the disease. Despite major efforts to understand the cellular pathophysiology of CD there are still relevant open questions to be addressed. In the present investigation we aimed to evaluate the contribution of the Na+/Ca2+ exchanger (NCX) in the electrical remodeling of isolated cardiomyocytes from an experimental murine model of chronic CD.
Methodology/principal findings: Male C57BL/6 mice were infected with Colombian strain of Trypanosoma cruzi. Experiments were conducted in isolated left ventricular cardiomyocytes from mice 180-200 days post-infection and with age-matched controls. Whole-cell patch-clamp technique was used to measure cellular excitability and Real-time PCR for parasite detection. In current-clamp experiments, we found that action potential (AP) repolarization was prolonged in cardiomyocytes from chagasic mice paced at 0.2 and 1 Hz. After-depolarizations, both subthreshold and with spontaneous APs events, were more evident in the chronic phase of experimental CD. In voltage-clamp experiments, pause-induced spontaneous activity with the presence of diastolic transient inward current was enhanced in chagasic cardiomyocytes. AP waveform disturbances and diastolic transient inward current were largely attenuated in chagasic cardiomyocytes exposed to Ni2+ or SEA0400.
Conclusions/significance: The present study is the first to describe NCX as a cellular arrhythmogenic substrate in chagasic cardiomyocytes. Our data suggest that NCX could be relevant to further understanding of arrhythmogenesis in the chronic phase of experimental CD and blocking NCX may be a new therapeutic strategy to treat arrhythmias in this condition.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g006.gif)
![Fig 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g007.gif)
![Fig 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g008.gif)
![Fig 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g009.gif)
![Fig 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8172059/bin/pntd.0009421.g010.gif)
Similar articles
-
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.J Mol Cell Cardiol. 2015 Apr;81:81-93. doi: 10.1016/j.yjmcc.2015.01.013. Epub 2015 Jan 30. J Mol Cell Cardiol. 2015. PMID: 25644533 Free PMC article.
-
Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias.Br J Pharmacol. 2014 Dec;171(24):5665-81. doi: 10.1111/bph.12867. Br J Pharmacol. 2014. PMID: 25073832 Free PMC article.
-
Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor.Circ J. 2010 Nov;74(12):2712-9. doi: 10.1253/circj.cj-10-0652. Epub 2010 Oct 30. Circ J. 2010. PMID: 21048325
-
Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases.Curr Med Chem. 2009;16(25):3294-321. doi: 10.2174/092986709788803268. Curr Med Chem. 2009. PMID: 19548864 Review.
-
The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.Cardiovasc Res. 2008 Jun 1;78(3):476-84. doi: 10.1093/cvr/cvn031. Epub 2008 Feb 5. Cardiovasc Res. 2008. PMID: 18252759
Cited by
-
Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside.Circ Res. 2024 May 10;134(10):1379-1397. doi: 10.1161/CIRCRESAHA.124.324507. Epub 2024 May 9. Circ Res. 2024. PMID: 38723031 Free PMC article. Review.
-
Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology.PLoS Negl Trop Dis. 2024 Feb 1;18(2):e0011865. doi: 10.1371/journal.pntd.0011865. eCollection 2024 Feb. PLoS Negl Trop Dis. 2024. PMID: 38300899 Free PMC article. Review.
-
Winding Down the Storm: Could Empagliflozin's Ion-Dependent Mechanisms Tackle the Ventricular Arrhythmia Burden in Chronic Chagas Cardiomyopathy?Cardiovasc Drugs Ther. 2024 Feb;38(1):203-205. doi: 10.1007/s10557-023-07510-8. Epub 2023 Oct 16. Cardiovasc Drugs Ther. 2024. PMID: 37843718 No abstract available.
-
The Role of the Na+/Ca2+ Exchanger in Aberrant Intracellular Ca2+ in Cardiomyocytes of Chagas-Infected Rodents.Front Cell Infect Microbiol. 2022 Jul 7;12:890709. doi: 10.3389/fcimb.2022.890709. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35903196 Free PMC article.
References
-
- WHO. Fact sheets-Chagas disease. World Health Organization. 2020:1.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous